By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Vifor Pharma 

Flughofstrasse 61

Glattbrugg    CH-8152  Switzerland
Phone: 41-58-8518000 Fax: 41-58-8518001



Company News
Bay Area Biotech Nabs $50 Million Cash Upfront in Partnership Expansion With Vifor Pharma 12/27/2016 7:08:46 AM
Bay Area's ChemoCentryx (CCXI) Inks $85 Million Deal With Vifor Pharma for Lead Product Candidate 5/11/2016 7:04:38 AM
Emirates Gastroenterology & Hepatology Society And Vifor Pharma Collaborate To Advance Iron Deficiency (ID) Management In UAE 12/17/2015 10:41:40 AM
Vifor Pharma Enters Two-Year Detailing Agreement With Sanofi (SNY) In The United States 8/11/2015 7:55:14 AM
Vifor Pharma Announces Opening Of First Office In The Middle East 4/29/2015 9:16:53 AM
Vifor Pharma Release: CONFIRM-HF Study Demonstrates That Injectafer® (Ferinject®) Improves Exercise Capacity In Patients With Chronic Heart Failure 9/2/2014 8:10:20 AM
American Regent Inc.'s Injectafer® (ferric carboxymaltose injection) Receives FDA Approval for the Treatment of Iron Deficiency Anemia 7/26/2013 7:42:25 AM
Debiopharm and Vifor Pharma Sign an Exclusive Agreement for the Distribution and Commercialization of PamorelinĀ®LA in Switzerland - A Drug Treatment for Prostate Cancer and Endometriosis 5/15/2012 10:36:31 AM
Isotechnika Pharma Inc. (ISA.TO) Enters Into Development and Commercialization License Agreement With Vifor Pharma 1/3/2012 9:28:39 AM
Lupus Foundation of America, Inc. Release: Research Presented at the 9th International Lupus Congress Provides Hope and Encouragement for the Future Treatment and Management of Lupus 6/25/2010 11:33:50 AM